Interventions. Copies: This document is available on the World Wide Web sites of the
American College of Cardiology (www. cardiosource. org), the American Heart Association …

Steven M. Ettinger, MD, FACC, Robert A. Guyton, MD, FACC, Jonathan L. Halperin, MD,
FACC, FAHA, Judith S. Hochman, MD, FACC, FAHA, Frederick G. Kushner, MD, FACC …

OBJECTIVES: To develop and validate a new risk-of-bias tool for nonrandomized studies
(NRSs). STUDY DESIGN AND SETTING: We developed the Risk of Bias Assessment Tool …

The recommendations listed in this document are, whenever possible, evidence based. An
extensive evidence review was conducted through November 2010, as well as selected …

Background Approximately 3.7 million people died from acute coronary syndrome
worldwide in 2012. Acute coronary syndrome, also known as myocardial infarction or …

Real‐world data are considered a potentially valuable source of evidence for assessing
medical technologies in clinical practice, but their widespread use is hampered by …

Bioresorbable coronary vascular scaffolds are about to revolutionize the landscape of
interventional cardiology. These scaffolds, consisting of a poly (l‐lactic acid) interior and a …

Background Cardiovascular disease and cancer frequently coexist, and patients with cancer
are at increased risk of cardiovascular events, including myocardial infarction and stroke …

Angina pectoris is a treatable symptom that is associated with mortality and decreased
quality of life. Angina eradication is a primary care goal of care after an acute myocardial …

Background Different stents implantation in ST-segment elevation myocardial infarction
(STEMI) patients may influence the long term prognosis by affecting vessel healings after …